Biotalys (BTLS.BR) Stock Price
Biotalys Price
The consensus 12-month price target for Biotalys is 6.12 EUR, about 277.8% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
Biotalys stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Biotalys business model & stock analysis
Frequently asked questions about Biotalys
9 analysts currently rate the Biotalys stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Biotalys to generate revenue of 13.24 M EUR and earnings per share of -0.43 EUR.
The Biotalys share (BTLS.BR) is listed on 4 stock exchanges, including: Frankfurt (86C.F), München (86C.MU).
The expected revenue of Biotalys is 13.24 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Biotalys is -15.97 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Biotalys is currently -3.81. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biotalys stock.
The price-to-sales ratio (P/S) of Biotalys is currently 4.59. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biotalys stock.
The Eulerpool Quality Score for Biotalys is 2/10.
The ISIN of Biotalys is BE0974386188. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Biotalys is A3CS50. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Biotalys is BTLS.BR. The ticker symbol is used to trade Biotalys shares on the stock exchange.
Biotalys stock
Biotalys Peer Group
Biotalys Ticker
Biotalys FIGI
All fundamentals and in-depth analysis of Biotalys
Our stock analysis for Biotalys stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotalys. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.